{"product_id":"dietary-supplements-nobel-science-or-misleading-marketing-inside-the-controversy-behind-elysiums-basis","title":"Dietary Supplements: Nobel Science or Misleading Marketing? Inside the Controversy Behind Elysium's \"Basis\"","description":"\u003cp\u003eDietary supplements are a massive industry with over $20 billion in annual US sales, yet most products have little or no evidence behind their health claims. This opinion piece from a former Harvard Medical School dean examines the controversy surrounding Elysium Health's supplement \"Basis,\" which recruited seven Nobel laureates as advisors despite having no proven health benefits. The article raises serious questions about whether these distinguished scientists are helping reform the supplement industry or simply lending their reputations to marketing efforts in a lightly regulated marketplace.\u003c\/p\u003e\n\n\u003ch1\u003eDietary Supplements: Nobel Science or Misleading Marketing? Inside the Controversy Behind Elysium's \"Basis\"\u003c\/h1\u003e\n\n\u003ch2\u003eTable of Contents\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\u003ca href=\"#ddn-key-points\"\u003eKey Points\u003c\/a\u003e\u003c\/li\u003e\n\n  \u003cli\u003e\u003ca href=\"#background\"\u003eThe $20 Billion Supplement Industry\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"#regulation\"\u003eHow Supplements Are Regulated (and Why It Matters)\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"#aging-science\"\u003eThe Science of Aging: Real Promise or Distant Dream?\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"#elysium\"\u003eInside Elysium: The Story of \"Basis\"\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"#nobel\"\u003eThe Nobel Laureate Connection\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"#clinical-trial\"\u003eWhat the \"Clinical Trial\" Actually Showed\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"#narratives\"\u003eTwo Conflicting Views of Elysium\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"#patient-takeaways\"\u003eWhat This Means for Patients\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"#limitations\"\u003eLimitations of This Analysis\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"#recommendations\"\u003eRecommendations for Supplement Users\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"#ddn-faq\"\u003eFrequently Asked Questions\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#source\"\u003eSource Information\u003c\/a\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003c!-- ddn:keypoints:start --\u003e\n\u003ch2 id=\"ddn-key-points\"\u003eKey Points\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003eMost dietary supplements have little or no scientific evidence for their claimed health benefits, despite $20 billion in annual US sales.\u003c\/li\u003e\n\u003cli\u003eUnlike prescription drugs, supplements can be sold without prior FDA approval and often lack proof of effectiveness or safety.\u003c\/li\u003e\n\u003cli\u003eElysium's Basis contains nicotinamide riboside and pterostilbene, which have shown benefits in cells and animals but not proven benefits in humans.\u003c\/li\u003e\n\u003cli\u003eAn unpublished study showed Basis increased NAD levels, but that does not prove improved cellular health or any health outcome.\u003c\/li\u003e\n\u003cli\u003ePatients should look for clinical trial evidence, be skeptical of celebrity endorsements, and talk to their doctor before taking supplements.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c!-- ddn:keypoints:end --\u003e\n\n\n\u003ch2 id=\"background\"\u003eThe $20 Billion Supplement Industry\u003c\/h2\u003e\n\n\u003cp\u003eMillions of Americans seeking improved health take \"natural product\" dietary supplements—everything from Gobi berries to Echinacea. The supplement industry sells vitamins, minerals, herbs, botanicals, and a growing list of other \"natural\" substances, bringing in more than \u003cstrong\u003e$20 billion in annual US revenue\u003c\/strong\u003e. That's a staggering amount of money flowing through an industry with remarkably loose oversight.\u003c\/p\u003e\n\n\u003cp\u003eYet here's the uncomfortable truth: most of these products have little or no scientific evidence that they actually confer health benefits. This disconnect has created ongoing struggles between the supplement industry and the medical science community—struggles that are hardly surprising given what's at stake financially and for public health.\u003c\/p\u003e\n\n\u003cp\u003eSo when seven Nobel laureates attached their names to a company marketing an unproven dietary supplement, eyebrows were raised across the scientific community. This was especially notable at a time when the integrity and reproducibility of bioscience research was already being questioned. The product in question was marketed as an \"anti-aging\" supplement that improves \"cellular health\" (though a correction to the original article clarified that Elysium itself does not use the phrase \"anti-aging\" in its marketing materials for Basis). This description connects it to a long lineage of \"cures,\" remedies, and \"miracle drugs\" that extend back at least as far as the myth of the Fountain of Youth.\u003c\/p\u003e\n\n\u003ch2 id=\"regulation\"\u003eHow Supplements Are Regulated (and Why It Matters)\u003c\/h2\u003e\n\n\u003cp\u003eThe regulatory path for bringing a supplement to market differs dramatically from that of prescription drugs. Prescription drugs must undergo rigorous testing through clinical trials and receive approval from the FDA before they can be sold. Supplements face no such requirement.\u003c\/p\u003e\n\n\u003cp\u003eHere's the key distinction that every patient should understand:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eSupplements \u003cstrong\u003ecannot legally claim\u003c\/strong\u003e to treat, cure, or prevent specific diseases\u003c\/li\u003e\n  \u003cli\u003eSupplements \u003cstrong\u003ecan claim\u003c\/strong\u003e, without any evidence, to affect the \"structure and function\" of the body\u003c\/li\u003e\n  \u003cli\u003eMany supplements claim to extend life and improve various symptoms, but industry standards are inconsistent and widely criticized\u003c\/li\u003e\n  \u003cli\u003eProducts may not actually contain the labeled substances in the specified amounts\u003c\/li\u003e\n  \u003cli\u003eSome supplements contain harmful contaminants\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003eThe regulatory and legal system currently in place isn't up to the task of addressing these issues. This means patients are essentially being asked to trust manufacturers at their word, with no guarantee that what's on the label matches what's in the bottle—or that the product does anything beneficial at all.\u003c\/p\u003e\n\n\u003ch2 id=\"aging-science\"\u003eThe Science of Aging: Real Promise or Distant Dream?\u003c\/h2\u003e\n\n\u003cp\u003eIt's important to note that the science of aging is genuinely exciting. Researchers have found that manipulating specific genes in yeast, worms, and mice can increase their lifespan. These are real, reproducible findings in legitimate laboratories.\u003c\/p\u003e\n\n\u003cp\u003eHere's the promising part: the same genes exist in humans. This means that, theoretically, manipulating these genes could lead to treatments for human age-related diseases, and potentially for aging itself. This is not fringe science—it's at the cutting edge of contemporary biomedical research.\u003c\/p\u003e\n\n\u003cp\u003eBut here's the catch that often gets lost in the marketing: \u003cstrong\u003etranslating such insights from the laboratory to the clinic is challenging\u003c\/strong\u003e. Despite decades of promising research, no therapies based on these ideas have emerged. The gap between \"this works in a worm\" and \"this works in a human patient\" is enormous, and it's a gap that supplement marketing often glosses over entirely.\u003c\/p\u003e\n\n\u003ch2 id=\"elysium\"\u003eInside Elysium: The Story of \"Basis\"\u003c\/h2\u003e\n\n\u003cp\u003eEnter Elysium Health. Backed by top-tier venture capital, the company crafted a business opportunity in the supplement world. Their strategy was clever: they identified two marketed \"natural molecules\" with plausible but unproven benefit, combined them into a new pill, packaged it attractively, and named it \u003cstrong\u003eBasis\u003c\/strong\u003e.\u003c\/p\u003e\n\n\u003cp\u003eThe two ingredients in Basis are:\u003c\/p\u003e\n\u003col\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNicotinamide riboside\u003c\/strong\u003e — a version of vitamin B3\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePterostilbene\u003c\/strong\u003e — an antioxidant found in blueberries\u003c\/li\u003e\n\u003c\/ol\u003e\n\n\u003cp\u003eBoth ingredients have produced benefits in cells and animals in laboratory studies, and both are generally viewed as safe for human consumption. But benefit in a petri dish or a mouse is a far cry from proven benefit in a human body.\u003c\/p\u003e\n\n\u003cp\u003eTo differentiate themselves from other supplement providers, Elysium engaged a highly regarded researcher—\u003cstrong\u003eMIT's Leonard Guarente\u003c\/strong\u003e—as scientific founder and the public face of the company. Guarente made important discoveries about aging in yeast. He had been frustrated by unsuccessful efforts to develop anti-aging drugs through the FDA approval process, so he sought another path. Along with Elysium, he recruited seven Nobel laureates to advise the company and lend their names to its efforts.\u003c\/p\u003e\n\n\u003cp\u003eWith Nobelists on board, additional outstanding scientists became advisors as well. Using sophisticated advertising and social media, the company sells Basis directly to consumers, promoting vague health benefits linked to the glow of scientific stars.\u003c\/p\u003e\n\n\u003ch2 id=\"nobel\"\u003eThe Nobel Laureate Connection\u003c\/h2\u003e\n\n\u003cp\u003eThe use of Nobel Prize winners as advisors is unusual in the supplement world, and it raises uncomfortable questions. In 2015, the Boston Globe reported on Elysium's launch in a story featuring two Nobelists from Harvard. At the time, Jeffrey Flier was the dean of Harvard Medical School, and he received expressions of concern from faculty members who saw financial incentives driving an otherwise inexplicable association. Flier initially thought that explanation unlikely, but he was genuinely puzzled by the arrangement.\u003c\/p\u003e\n\n\u003cp\u003eFlier contacted one of the Nobel laureates directly: \u003cstrong\u003eEric Kandel\u003c\/strong\u003e, professor of neuroscience at Columbia and chair of Elysium's scientific advisory board. Kandel won the Nobel Prize in 2000 for fundamental discoveries about the cellular basis of memory, and he remains active and vital at age 87.\u003c\/p\u003e\n\n\u003cp\u003eWhen asked about his association with Elysium, Kandel cited the importance of new approaches to aging and defended the plausibility of the science. He lauded the company's commitment to clinical trials—a rare feature among supplement companies. However, when reminded that people were being treated without such trials, he admitted unhappiness about this and said he hoped the practice would change. He was also uncomfortable that Nobel prizes were being used as a marketing strategy.\u003c\/p\u003e\n\n\u003cp\u003eFive other advisors praised Elysium's strategy for developing safe and effective natural products. They stressed the importance of clinical trials, but they weren't clear about how these trials would be conducted or how the results would be used. Here's perhaps the most telling detail: \u003cstrong\u003enone of them recommended that people take Basis\u003c\/strong\u003e.\u003c\/p\u003e\n\n\u003ch2 id=\"clinical-trial\"\u003eWhat the \"Clinical Trial\" Actually Showed\u003c\/h2\u003e\n\n\u003cp\u003eElysium does promote one feature that's unique among supplement companies: an intention to perform clinical trials. But a closer look at what they've actually produced is revealing.\u003c\/p\u003e\n\n\u003cp\u003eAn unpublished study promoted on their website claims that Basis increases levels of a key molecule called \u003cstrong\u003eNAD\u003c\/strong\u003e (nicotinamide adenine dinucleotide), which plays a role in cellular energy and metabolism. While potentially of scientific interest, this \"trial\" provides no evidence that Basis improves \"cellular health\" — which is, after all, the stated goal of taking the supplement.\u003c\/p\u003e\n\n\u003cp\u003eMeasuring one molecule in the blood does not prove that a product makes cells healthier, slows aging, or improves any health outcome. The history of drug development is filled with examples where promising results in animals and cells failed to translate into actual health benefits in humans.\u003c\/p\u003e\n\n\u003ch2 id=\"narratives\"\u003eTwo Conflicting Views of Elysium\u003c\/h2\u003e\n\n\u003cp\u003eFlier presents two conflicting narratives to describe the company. Understanding these two perspectives is essential for any patient considering whether to take a supplement like Basis.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eNarrative One: The Skeptical View.\u003c\/strong\u003e In this version, Elysium sells supplements in a lightly regulated and evidence-free environment. The company leverages the reputations of great scientists to add credibility to its marketing. It overstates the narrative about clinical trials to sell products, with sales having primacy over health efficacy.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eNarrative Two: The Reformist View.\u003c\/strong\u003e In this version, Elysium is genuinely reforming the supplement industry by engaging great scientists and rigorously testing products to establish or refute health benefits. The clinical trials are real, and the company's intentions are honorable.\u003c\/p\u003e\n\n\u003cp\u003eWhich narrative more closely resembles reality? Flier argues that the answer depends on what the scientific advisors do next. They could use their clout to promote the second version by insisting that their Nobel credentials not be employed as marketing tools, and by demanding that Basis—and any future products—be shown to have real efficacy before being marketed, even if not legally required.\u003c\/p\u003e\n\n\u003ch2 id=\"patient-takeaways\"\u003eWhat This Means for Patients\u003c\/h2\u003e\n\n\u003cp\u003eFor patients, this story carries several important lessons. First, \u003cstrong\u003ea prestigious name on a product does not equal scientific proof\u003c\/strong\u003e. The Nobel laureates associated with Elysium are brilliant scientists, but even their own advisors didn't recommend that people take the product.\u003c\/p\u003e\n\n\u003cp\u003eSecond, the ingredients in Basis might improve health—they deserve careful study. But the history of drug development reveals that despite hopeful results in animals and cells, and despite the good intentions of Elysium's advisors, it's unlikely that Basis improves health in the ways its marketing suggests.\u003c\/p\u003e\n\n\u003cp\u003eThird, the supplement industry operates with far less oversight than the prescription drug industry. The regulatory and legal system isn't equipped to ensure supplements contain what they claim or do what they promise. Patients should understand that buying a supplement is fundamentally different from taking a FDA-approved medication—you're accepting a much higher level of uncertainty about both safety and effectiveness.\u003c\/p\u003e\n\n\u003cp\u003eFinally, this controversy has implications beyond one product. If the supplement industry could more closely mirror properly documented medical research, the nation's health might genuinely be enhanced. The scientific advisors at Elysium have the opportunity to model what that could look like—by insisting that products be proven effective before being marketed, even when not legally required.\u003c\/p\u003e\n\n\u003ch2 id=\"limitations\"\u003eLimitations of This Analysis\u003c\/h2\u003e\n\n\u003cp\u003eThis article is an opinion piece by Dr. Jeffrey S. Flier, distinguished service professor at Harvard Medical School and former dean of the school. It is not a peer-reviewed scientific study, and it does not present new clinical trial data. The analysis is based on Flier's expertise, his review of Elysium's practices, and his interviews with advisors, including Eric Kandel.\u003c\/p\u003e\n\n\u003cp\u003eFlier's description of Elysium is based on publicly available information and his conversations with company advisors. The unpublished study mentioned in the article was not independently verified. It's also worth noting that a correction was issued to the original article: Elysium does not use the phrase \"anti-aging\" in its marketing materials for Basis, though the supplement is widely understood to be positioned as an anti-aging product.\u003c\/p\u003e\n\n\u003cp\u003eAdditionally, this piece does not evaluate whether any individual supplement—including Basis—is harmful or beneficial. It focuses specifically on the marketing practices and scientific evidence (or lack thereof) behind one product.\u003c\/p\u003e\n\n\u003ch2 id=\"recommendations\"\u003eRecommendations for Supplement Users\u003c\/h2\u003e\n\n\u003cp\u003eBased on the issues raised in this article, here are practical steps patients can take when considering any dietary supplement:\u003c\/p\u003e\n\n\u003col\u003e\n  \u003cli\u003e\n\u003cstrong\u003eLook for clinical trial evidence, not just laboratory studies.\u003c\/strong\u003e Results in cells or animals do not predict benefits in humans. Ask whether the product has been tested in randomized, controlled human trials published in reputable medical journals.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eBe skeptical of celebrity endorsements—including scientist celebrity endorsements.\u003c\/strong\u003e A Nobel Prize validates past scientific achievements, not the effectiveness of a commercial product.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eCheck whether the product has been independently tested.\u003c\/strong\u003e Third-party testing organizations can verify that a supplement contains what its label claims, though they cannot verify health benefits.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTalk to your doctor before taking supplements.\u003c\/strong\u003e Some supplements can interact with prescription medications or cause harm in certain medical conditions.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAsk what the clinical trials actually measured.\u003c\/strong\u003e A supplement company may point to a study showing changes in a blood marker, but that doesn't mean the product improves health outcomes like longevity, disease prevention, or quality of life.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eBe wary of vague health claims.\u003c\/strong\u003e Terms like \"cellular health,\" \"vitality,\" and \"support\" are often used to suggest benefits without making specific, testable claims.\u003c\/li\u003e\n\u003c\/ol\u003e\n\n\u003cp\u003eThe bottom line: the dietary supplement industry is a $20 billion business operating with minimal regulation and, frequently, minimal scientific evidence. The involvement of respected scientists in companies like Elysium is a double-edged sword—it could lead to much-needed reform, or it could simply lend an air of legitimacy to unproven products. For now, patients should approach all supplements, regardless of marketing, with informed skepticism and honest conversations with their healthcare providers.\u003c\/p\u003e\n\n\u003c!-- ddn:faq:start --\u003e\n\u003ch2 id=\"ddn-faq\"\u003eFrequently Asked Questions\u003c\/h2\u003e\n\u003ch3\u003eWhy did Nobel laureates associate with Elysium Health's supplement Basis?\u003c\/h3\u003e\n\u003cp\u003eSeven Nobel laureates joined Elysium's advisory board. One, Eric Kandel, said he supported new approaches to aging and praised the company's commitment to clinical trials. However, he was uncomfortable that Nobel prizes were used as marketing and did not recommend that people take Basis. Other advisors stressed clinical trials but were unclear on how results would be used.\u003c\/p\u003e\n\u003ch3\u003eWhat did the clinical trial for Basis actually show?\u003c\/h3\u003e\n\u003cp\u003eAn unpublished study promoted on Elysium's website showed that Basis increased levels of NAD, a molecule involved in cellular energy. But this did not prove that the supplement improves cellular health, slows aging, or improves any health outcome. Measuring one molecule in the blood is not evidence of real health benefits.\u003c\/p\u003e\n\u003ch3\u003eIs there real science behind anti-aging treatments?\u003c\/h3\u003e\n\u003cp\u003eYes, research in yeast, worms, and mice has shown that manipulating certain genes can increase lifespan, and these genes exist in humans. However, translating these findings to human treatments is very challenging, and despite decades of research, no therapies based on these ideas have emerged. The gap between animal studies and human benefits is enormous.\u003c\/p\u003e\n\u003ch3\u003eWhat are the ingredients in Elysium's Basis supplement?\u003c\/h3\u003e\n\u003cp\u003eBasis contains two ingredients: nicotinamide riboside, a version of vitamin B3, and pterostilbene, an antioxidant found in blueberries. Both have shown benefits in cells and animals in laboratory studies and are generally viewed as safe for human consumption, but neither has proven benefit in humans.\u003c\/p\u003e\n\u003ch3\u003eWhat should patients consider before taking a dietary supplement?\u003c\/h3\u003e\n\u003cp\u003eLook for evidence from randomized, controlled human trials published in reputable journals, not just lab studies. Be skeptical of endorsements, including from scientists, because a Nobel Prize does not validate a product. Check if the product was independently tested, ask your doctor about interactions, and be wary of vague claims like 'cellular health' or 'vitality'.\u003c\/p\u003e\n\u003ch3\u003eDid Elysium's scientific advisors recommend taking Basis?\u003c\/h3\u003e\n\u003cp\u003eNo. None of the advisors interviewed recommended that people take Basis. While they praised Elysium's strategy and stressed the importance of clinical trials, they did not endorse the product for personal use. This suggests that even the scientists involved did not see enough evidence to recommend it to patients.\u003c\/p\u003e\n\u003ch3\u003eShould I get a second opinion before taking a dietary supplement like Basis?\u003c\/h3\u003e\n\u003cp\u003eBefore taking any dietary supplement marketed with vague health claims such as 'cellular health' or 'vitality,' a second opinion is worth seeking. The supplement industry operates with minimal regulation, and products are not required to prove they work. A prestigious scientist's name does not equal proof; even the Nobel advisors associated with Elysium's Basis did not recommend taking it. A second opinion can help clarify whether a product has randomized controlled human trial evidence, whether claims are specific, and whether it is safe alongside your current medications. Diagnostic Detectives Network provides independent expert second opinions.\u003c\/p\u003e\n\u003c!-- ddn:faq:end --\u003e\n\n\u003ch2 id=\"source\"\u003eSource Information\u003c\/h2\u003e\n\n\u003cp\u003e\u003cstrong\u003eOriginal article title:\u003c\/strong\u003e Dietary supplements  Nobel or ignoble - The Boston Globe\u003c\/p\u003e\n\n\u003cp\u003e\u003cem\u003eNote: This patient-friendly article is based on peer-reviewed research and expert commentary originally published in The Boston Globe. The original article included a correction noting that Elysium does not use the phrase \"anti-aging\" in its marketing materials for Basis.\u003c\/em\u003e\u003c\/p\u003e","brand":"DiagnosticDetectives.Com","offers":[{"title":"Default Title","offer_id":47471121432732,"sku":null,"price":0.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/diagnosticdetectives.com\/products\/dietary-supplements-nobel-science-or-misleading-marketing-inside-the-controversy-behind-elysiums-basis","provider":"DiagnosticDetectives.Com","version":"1.0","type":"link"}